NEW YORK -- Wound care products used to treat traumatic injury and surgical wounds will garner revenues in excess of $4.3 billion in 2003, according to a new study released today by Kalorama Information. Although these wound types represent over half of the total wound care market, the impressive gains of the past few years will be slowing.
The study, "Wound Care Markets Volume III: Surgical and Trauma Wounds," revealed that wound closure devices continue to dominate the segment. However, the explosive growth displayed by the newer technologies in wound closure, such as adhesives and sealants -- which was a major driver for the segment -- will slow significantly over the next five years. Likewise, the biological dressings segment, parts of which showed greater than 35 percent compound annual growth in the past few years, should also fall in line with the rest of wound markets by 2005.
"The introduction of novel closure methods and growth factors have had their impact," notes Steven Heffner, acquisitions editor for Kalorama Information. "Although many are still predicting a rosy market scenario, we think the next wave of technologies is a few years off and that the coming five years will be a time of maturation in the marketplace."
The study analyzes the world market for products used in surgical and trauma wounds including sutures, staples, adhesives, and sealants; anti-infective products; cleansing, debridement, tapes, and dry dressings; moist dressings, such as alginates, hydrocolloids, hydrogels, films, and foams; biological products such as artificial skin, collagen, and growth factor; and other treatments. The study represents the third and final volume in a seven-month study of wound care markets by specific indication. The previous two volumes looked at the skin ulcer and burn segments, respectively.
Kalorama Information, an imprint of MarketResearch.com, supplies the latest in independent market research for the life sciences.